Abstract Submissions
Be part of the CHEST 2008 program by submitting an abstract of your original investigative work for presentation during the meeting. This is your opportunity to:
- Gain national and international exposure by presenting accepted abstracts at CHEST 2008. Abstracts will be made available to conference attendees to review during presentations.
- Receive feedback from an interdisciplinary mix of chest and critical care medicine specialists. Based on past meeting experience, we anticipate that physicians and allied health-care professionals from all fields related to chest medicine will be in attendance to review and comment on your work.
- Participate with the American College of Chest Physicians (ACCP) in efforts to fight chest diseases. By presenting your findings, you join the ACCP in its mission to advance the prevention and treatment of chest diseases through research and education.
- Compete for The CHEST Foundation investigative awards. Cash awards are granted to researchers whose works are judged to be outstanding by the reviewers and moderators. All primary authors of accepted abstracts are eligible to win.
Abstract Submission Deadline: April 30, 2008
Abstract Submission for CHEST 2008
It's Free. It's Easy.
Abstract submission for CHEST 2008 is FREE. Domestic and international submissions are encouraged.
Using the program, you can create a user name and password, enter your abstract, save it, and return to it from anywhere you have Internet access. You can edit and update your abstract anytime before the deadline by returning to the Web site, logging in, and clicking on the Review and Update My Submissions button. Your final submission must be made on or before April 30, 2008, 1:00 pm (CT).
Electronic confirmation of your agreement with the Abstract Author Agreement must accompany your submission. Among other things, this agreement requires that, for abstracts relating to human research, investigational protocols must be reviewed and approved by a formally constituted institutional review board for human studies.
For the best results, use Internet Explorer 6.0 or higher. Program enhancements may not be available if a lower version of Netscape or Internet Explorer is used.
After the submission deadline, all completed and submitted abstracts will be sent to graders for review. Incomplete abstracts will not be sent for review.
Receipt of abstracts will be acknowledged electronically to the presenting author. Requests for phone acknowledgments will not be accepted.
Abstracts will be evaluated individually on scientific merit and originality. Notification of acceptance or rejection will be made electronically to the presenting author after July 7, 2008. If you have not been notified by July 18, 2008, please contact the ACCP.
If you do not respond to the ACCP by August 1, 2008, stating your acceptance or decline to present at CHEST 2008, your abstract will automatically be removed.
For assistance, contact techelp@chestnet.org.
Abstract Submission Guidelines
Abstracts must comply with the following guidelines. Abstracts will be rejected for not meeting submission criteria.
- Abstracts must be written and presented in English.
- The material submitted must be original and may not be presented or published elsewhere in abstract form prior to October 30, 2008.
- Submission of an abstract constitutes the author’s commitment to present the abstract, as accepted, at CHEST 2008.
- The abstract title should clearly define the topic and contain no abbreviations. Standard abbreviations may be used in the text of the abstract. On first use, spell out the full term and follow with the abbreviation in parentheses. Author names are not allowed in the title of the abstract; author names should be entered in the designated author information area.
- All submissions must be HIPAA compliant.
- All text must be submitted in the text box. You may use a table to highlight an important feature of the written content. Inclusion of a table has no impact on the decision to accept or reject an abstract. Tables will not be published.
- The total word count, excluding the optional table, may not exceed 325 words.
- Proprietary names of drugs are not allowed. Generic names must be used.
- Multiple abstracts focusing on several different aspects of the same study will not be accepted. The Scientific Presentations and Awards Committee may request that you combine them into a single abstract.
- Abstracts submitted as case reports and/or literature reviews will not be accepted for abstract presentation. To submit a case report, use the Submit a Case Report link on the submission page.
- When submitting, select all relevant presentation categories, and ensure that all contact information is correct.
- Conflicts of interest must be disclosed. If you have nothing to disclose, indicate this by checking the appropriate box. Failure to disclose any grant support or funding will disqualify an abstract.
- The last day to edit or withdraw your accepted abstract is August 1, 2008. To withdraw your accepted abstract, e-mail Lisa Roeber at lroeber@chestnet.org. Please include your abstract control number.
The ACCP reserves the right to reject abstracts for any reason, including failure to meet submission requirements and special scheduling requirements of CHEST 2008.
Abstract Publication and Presentations
Abstract Publication Guidelines
- Accepted abstracts will be available to CHEST 2008 attendees and ACCP membership.
- Abstracts will be provided to attendees exactly as submitted through the online program; however, tables will not be used.
Abstract Presentation Guidelines
- The ACCP and Scientific Presentations and Awards Committee will determine the format of accepted abstracts: slide session or thematic poster. All decisions are final.
- Commercial logos are prohibited from appearing on poster or slide presentations.
- Authors scheduled for poster presentations will be assigned poster space during the poster grand rounds time and will be expected to display illustrative materials (eg, graphs, charts, etc). If you do not show up, or do not have a coauthor present in your place, you may not be invited to attend future meetings.
- Authors scheduled for slide presentations will have a specified amount of time to present and discuss the abstract. If you do not show up, or do not have a coauthor present in your place, you may not be invited to attend future meetings.
- Expenses associated with the preparation, submission, and presentation of abstracts are the responsibility of the author/presenter. If accepted, the presenter is required to pay all fees associated with the meeting, including, but not limited to, travel, housing accommodations, meeting registration, etc.
- Changes to accepted abstracts will be considered on a case-by-case basis. All changes must be submitted to the ACCP in writing, including the abstract title, author, presentation type, presentation category, and presentation day and time. The last day to edit or withdraw your accepted abstract is August 1, 2008. To withdraw your accepted abstract, e-mail Lisa Roeber at lroeber@chestnet.org. Please include your abstract control number.
Sample Abstract:
This is a sample for publication and does not represent how your abstract will appear on the submission site.
Prevalence of Risk Factors for Obstructive Sleep Apnea in the United States: Results From the 2005 Sleep in America Poll
David M. Hiestand, University of Kentucky, Lexington, KY
PURPOSE:
Obstructive sleep apnea (OSA) is a common medical condition with serious adverse consequences, including car accidents, hypertension, and cardiovascular disease. There are few studies assessing the risk of OSA in the general population.
METHODS:
The National Sleep Foundation’s (NSF) 2005 Sleep in America Poll included the Berlin Questionnaire, a previously validated instrument for estimating risk of OSA. The Berlin
Questionnaire has three components, and those scoring high on at least two sections are considered at risk for OSA. The 2005 NSF poll surveyed 1,506 adults aged 18 and over via telephone. This data was analyzed for the characteristics of respondents identified as being at risk for OSA.
RESULTS:
Overall, 26% of adults were found to be at risk for OSA, including 31% of men and 21% of women. The risk of OSA increased with age up to age 65: age 18 to 29, 19%; 30 to 49, 25%; and 50 to 64, 33%. Only 21% of individuals 65 and over were at risk. A total of 57% of obese individuals were at risk. Those at risk for OSA were more likely to report sleep problems (44% vs 9%). Those respondents reporting an impact of sleep on quality of life were at increased risk for OSA (41 vs 11 %). The presence of a chronic medical problem increased the likelihood of OSA (35% vs 11%).
CONCLUSIONS:
The NSF 2005 poll indicates a strikingly high risk of OSA in the US population. Risk is higher in men and higher in obese individuals. Risk, as defined by the Berlin Questionnaire, increases with age up to age 65. Individuals at risk for OSA are more likely to have a sleep problem and to believe this problem impacts quality of life. Finally, having other chronic medical problems is associated with increased risk of OSA.
CLINICAL IMPLICATIONS:
The prevalence of risk for OSA in the population is significant. Further emphasis on screening and evaluation is warranted.
DISCLOSURES:
Nothing to disclose.
The CHEST Foundation Awards
The CHEST Foundation confers awards to ACCP members in clinical research in chest and critical care medicine through its extensive awards program. In 2007, The CHEST Foundation proudly awarded over $675,000 for research, leadership in end-of-life care, and pro bono service. In 2008, it will continue the tradition of supporting important research and rewarding health-care professionals who are making a difference in the lives of patients and their families.
All primary authors of accepted abstracts are eligible for the following awards but will be allowed to win only one award. Only primary authors will be eligible for awards at CHEST 2008. Award recipients will be recognized at the Awards Presentation during CHEST 2008. The abstract must be presented at CHEST 2008; if the abstract cannot be presented by any of the authors, it will no longer be eligible for an award.
Top 5 Best Posters Award
The Top 5 Posters at CHEST 2008 will be chosen. Each of the five poster winners will receive $200. Finalists will be evaluated on their written abstract and quality of their poster presentation during CHEST 2008. All categories are eligible. Award recipients will be selected for their outstanding original scientific research by judges from the Scientific Presentations and Awards Committee.
Alfred Soffer Research Awards
Two $1,500 awards will be granted to the winners, and four $1,000 awards will be granted to the finalists submitting abstracts to CHEST 2008. Finalists will be evaluated on the basis of their written abstract and the quality of their oral presentation during CHEST 2008. Primary authors will be considered for all abstract-related awards but may win only one award. Award recipients will be selected for their outstanding original scientific research by judges from the Scientific Presentations and Awards Committee. This award is named in honor of Alfred Soffer, MD, Master FCCP, who was Editor in Chief of CHEST from 1968 to 1993 and Executive Director of the ACCP from 1969 to 1992.
Young Investigator Awards
A total of $12,250 will be granted to 10 abstract finalists at CHEST 2008. The top three winners will receive $2,275, and the remaining seven will be awarded $775. Investigators must be enrolled in a training or fellowship program or have completed a fellowship program within 5 years prior to CHEST 2008. Finalists will be evaluated on the basis of their written abstract and their presentations at CHEST 2008. Primary authors will be considered for all abstract-related awards but may only win one. Award recipients will be selected for their outstanding original scientific research by judges from the Scientific Presentations and Awards Committee. |
